MEDCL.PA
Medincell SA
Price:  
15.02 
EUR
Volume:  
177,856.00
France | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MEDCL.PA WACC - Weighted Average Cost of Capital

The WACC of Medincell SA (MEDCL.PA) is 7.7%.

The Cost of Equity of Medincell SA (MEDCL.PA) is 8.00%.
The Cost of Debt of Medincell SA (MEDCL.PA) is 6.85%.

Range Selected
Cost of equity 6.50% - 9.50% 8.00%
Tax rate 25.90% - 27.10% 26.50%
Cost of debt 6.70% - 7.00% 6.85%
WACC 6.3% - 9.0% 7.7%
WACC

MEDCL.PA WACC calculation

Category Low High
Long-term bond rate 3.0% 3.5%
Equity market risk premium 5.8% 6.8%
Adjusted beta 0.6 0.8
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.50% 9.50%
Tax rate 25.90% 27.10%
Debt/Equity ratio 0.12 0.12
Cost of debt 6.70% 7.00%
After-tax WACC 6.3% 9.0%
Selected WACC 7.7%